Literature DB >> 21528046

Exploring the possibility of an interferon-free treatment regimen for hepatitis C virus infection.

Mark Sulkowski1.   

Abstract

Entities:  

Year:  2011        PMID： 21528046      PMCID： PMC3079149     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  4 in total

1.  New direct-acting antivirals in the development for hepatitis C virus infection.

Authors:  Paul J Pockros
Journal:  Therap Adv Gastroenterol       Date:  2010-05       Impact factor: 4.409

Review 2.  New therapies in the management of hepatitis C virus.

Authors:  Anthony J Michaels; David R Nelson
Journal:  Curr Opin Gastroenterol       Date:  2010-05       Impact factor: 3.287

Review 3.  Future hepatitis C virus treatment: interferon-sparing combinations.

Authors:  Edward Gane
Journal:  Liver Int       Date:  2011-01       Impact factor: 5.828

4.  Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial.

Authors:  Edward J Gane; Stuart K Roberts; Catherine A M Stedman; Peter W Angus; Brett Ritchie; Rob Elston; David Ipe; Peter N Morcos; Linda Baher; Isabel Najera; Tom Chu; Uri Lopatin; M Michelle Berrey; William Bradford; Mark Laughlin; Nancy S Shulman; Patrick F Smith
Journal:  Lancet       Date:  2010-10-14       Impact factor: 79.321
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.